A Radiolife entregou nesta terça-feira (7/12), aos laboratórios parceiros, a versão final do Cubescan. The Covid-19 diagnostic equipment developed by the company is based on radio frequency technology.
Nesta última fase, ocorrem os ajustes finais. A previsão é de que o aparelho entre em operação ainda neste mês de dezembro. O equipamento para diagnóstico de Covid-19 apresenta resultado em 10 segundos. Além disso, o processamento não exige o uso de reagentes.
Radiolife is a startup based in Silicon Valley and, since March 2020, turned its research and development sector to the creation of a solution for diagnosis of the new coronavirus. The company of innovation and development of technologies to increase human longevity already had patented solutions for the health area. Among the solutions already developed is a technology for diagnosis and treatment of cancer, also based on radiofrequency.
Questions? Comments? Concerns? Contact us for more information. We'll quickly get back to you with the information you need.